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Abstract 
The cross-contamination of non-medicated feed with residues of antimicrobials (AM) causes 
a public and animal health concern associated with the potential for selection and 
dissemination of resistance. To analyze the associated risks, a probabilistic model was built 
using @Risk® (Palisade Corporation®) to show the potential extent of the effect of cross-
contaminated pig feed on resistance selection. The results of the model include estimations of 
the proportion of pigs per production stage with residues of doxycycline, chlortetracycline, 
sulfadiazine and trimethoprim in their intestinal contents, as a result of exposure to cross-
contaminated feed with different carry-over levels, in Belgium. By using a semi-quantitative 
approach, these estimations were combined with experimental data on AM concentrations 
associated with potential for resistance selection pressure. Based on this model it is estimated 
that 7.76% (min=1.67; max=36.94) of sows, 4.23% (min=1.01%; max=18.78%) of piglets 
and 2.8% (min=0.51%; max=14.9%) of fatteners in Belgium have residues of doxycycline in 
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their intestinal tract due to consumption of feed with at least 1% carry-over. These values 
were estimated to be almost triple for sulfadiazine, but substantially lower for 
chlortetracycline and trimethoprim. Doxycycline concentrations as low as 1 mg/L 
(corresponding to consumed feed with at least 1% carry-over) can select for resistant porcine 
commensal E. coli in vitro and in vivo. Conclusions on this risk could not be drawn for other 
AM at this stage, due to lack of literature data on concentrations associated with resistance 
development. However, since the possibility of resistance mechanisms (e.g. co-selection) 
occurring cannot be excluded, the results of this model highlight that the use of AM 
medicated feed should be minimized where possible. In case of medicated feed production, 
good practice should be followed thoroughly at all levels of production, distribution, storage 
and administration, with a special focus on the feed distributed to piglets and sows. 
Key words: medicated feed, cross-contamination, residues, antimicrobials, risk model 
 
Introduction 
The use of antimicrobial (AM) medicated feed (MF) can lead to cross-contamination of non-
medicated feed produced, transported and in-farm distributed directly after MF (Putier et al. 
2010; Stolker et al. 2012). A previously developed exposure model (Filippitzi et al. 2016) 
estimated that, in a country where MF represents 2% of the total feed produced in a year, a 
non-negligible 5.5% (95% CI = 3.4%; 11.4%) of the total feed produced in a year can contain 
residues of antimicrobials due to practices related to the production of medicated pig feed. 
This level corresponds, in the case of Belgium, to a mean weight of 356.5 tons of batches of 
pigs feed cross-contaminated with various levels of antimicrobials. In the case of consumption 
by pigs of this cross-contaminated feed, their intestinal microbiota is exposed to low, sub-
clinical concentration levels of antimicrobials (e.g. tetracycline, tylosin, sulfamethazine), 
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which can induce selection of resistant bacteria as demonstrated in vitro (Gullberg et al. 2011, 
2014) and in vivo (Brewer et al. 2013).  
The levels of AM contained in the cross-contaminated batches of feed vary considerably 
(Zuidema et al. 2010; Putier et al. 2010; Stolker et al. 2012). According to the recent proposal 
for a European Commission Regulation on medicated feed, 1% of an AM is suggested as the 
maximum carry-over limit allowed in the last flushing batch produced (i.e. a non-AM MF 
batch produced after MF at the feed mill to clean the production lines) (EC, 2014). So far, the 
Member States have followed different approaches. Some have no official values for tolerated 
carry-over, while others apply the zero tolerance principle (BFA 2013; EC 2016).  
With a view to determine the intestinal fecal concentrations of chlortetracycline (CTC), 
doxycycline (DOX) and sulfadiazine-trimethoprim (SDZ-TRIM) after administration of 
cross-contaminated feed to pigs, Peeters et al. (2016) set up an in vivo experiment, showing 
that the mean concentrations of 10mg/L CTC and 4 mg/L DOX reached in the feces were 
higher than concentrations that have been shown to cause resistance selection. Specifically for 
DOX, a 3% carry-over level in the feed resulted in porcine fecal concentrations of 
approximately 4 mg/L. Two studies that followed from the same research group (Peeters et al. 
2017, 2018) aimed to determine the effect of these residual DOX concentrations. The 
conclusion was that DOX intestinal concentrations of 1 and 4 mg/L, caused by feed cross-
contamination levels of approximately 1% and 3% respectively, can select for resistant 
porcine commensal Escherichia coli (E. coli) in vitro as well as in vivo. Even much lower 
concentrations of tetracycline (i.e. 15 ng/ml and 45 ng/ml) have been shown to select for 
resistance in vitro, based on competition experiments between resistant and susceptible strains 
(Gullberg et al. 2011, 2014). But also in vivo, Brewer et al. (2013) found that concentrations 
of tetracycline and sulfamethazine as low as 1 μg/mL in intestinal contents increased the 
frequency of transfer of resistance genes in pigs. This suggests that unintended low 
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antimicrobial concentrations can possibly exert selective pressure on resistant bacteria present 
and may co-select for other resistance genes carried by these bacteria, and consequently poses 
a serious concern for animal and public health and calls for targeted actions. 
Therefore, the first objective of this study was to build a probabilistic model that could be 
used to compare the extent of the exposure of piglets, sows and fattening pigs to cross-
contaminated feed considering different antimicrobials and different carry-over levels (e.g. 
1%, 3%). The second objective was to combine these with estimations on potential for 
resistance selection pressure, depending on the substance used. For illustration purposes, 
doxycycline was the substance used as example. The model was parametrized using data 
available in the literature and national data on feed production and antimicrobial use in 
Belgium. 
Materials and Methods 
Hazard identification 
Traces of antimicrobials may be incorporated into batches of non-medicated feed during their 
production, transport, unloading and/or storage and distribution at the farms. These cross-
contaminated batches of non-medicated feed are fed to pigs. The consumption of feed 
containing certain carry-over levels of some antimicrobials has been shown to result in 
residual antimicrobial concentrations in the intestinal content and feces of pigs (Peeters et al. 
2016), which can potentially select for resistance in vitro (Gullberg et al. 2011, 2014; Peeters 
et al. 2018) and in vivo (Brewer et al. 2013; Peeters et al. 2017). Therefore, as the hazard in 
this study, we considered the antimicrobial residues contained in intestinal contents of pigs 
which have consumed feed cross-contaminated due to practices related to the use of 
medicated feed. 
Model design 
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Figure 1 shows the model framework designed in order to estimate the number and proportion 
of pigs per production stage, which consume cross-contaminated feed and end up containing 
antimicrobial residues in their intestinal contents, in a country. If the concentration of these 
residues is higher than concentrations associated with resistance selection pressure, the model 
concludes that there is potential for resistance selection. Tables 1 and 2 describe the different 
variables of the model and the respective distributions, formulas or parameters used to 
estimate them. These tables represent a scenario that considers the presence of an 
antimicrobial in cross-contaminated batches in any possible concentration higher than zero 
(AM > 0; scenario A). The scenarios of 1% (scenario B) and 3% (scenario C) AM carry-over 
levels were also considered (Tables 3 and 4, respectively), as they lead to different 
concentration of residues in pigs and, therefore, to different potentials for resistance selection 
pressure. 
Model description and parametrization 
Number of pigs, per production stage, exposed to cross-contaminated feed, in a country (Ni) 
The number of pigs, per production stage, exposed to cross-contaminated feed, in a country 
(Ni) was estimated using the following equation (1): 
N(i) = WT’(i) / b(i) , (1) 
where WT’(i) is the total weight of cross-contaminated pig feed produced in a country i per 
year, reaching the pigs of different production stages, and b(i)  is the intake of cross-
contaminated feed per pig during a production stage i (Table 1). 
To estimate WT’(i), the equation (2) that follows was used: 
WT’(i) = (WT* Pa(i))/ y, (2) 
where WT is the total weight of cross-contaminated pig feed produced in a country per year, 
Pa(i) is the probability of the cross-contaminated feed WT being administered to pigs of certain 
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production stage i (i.e. piglets until 20 kg, sows, fattening pigs) (Table 2) and y is the number 
of production rounds per production stage in a random pig farm in a country, per year. 
To estimate the intake of cross-contaminated feed per pig during a certain production stage 
(b(i)), the following equation was used: 
b(i) = bd*da*n = (wb*n) / nb , (3) 
where bd refers to the daily feed intake of a pig at different production stages, da refers to the 
days of administration of a cross-contaminated feed batch, per production stage and equals da 
= wb / (bd * nb), n is the number of deliveries of cross-contaminated feed batches to a random 
farm, per production stage, wb is the weight of a cross-contaminated feed batch and nb is the 
number of pigs in a batch, per production stage in a farm, in a country.  
Table 2 presents in detail the estimation of Pa(i)  (i.e. the probability of the cross-contaminated 
feed WT being administered to pigs of certain production stage i), which is based on the 
equation: 
Pa(i) = WT(i) / WT ,  (4) 
where WT(i) is the total weight of cross-contaminated pig feed administered to pigs of a certain 
production stage i, per year and WT is the total weight of cross-contaminated pig feed 
produced in a country per year. The total weight of cross-contaminated pig feed administered 
to pigs of a certain production stage i (WT(i)) was calculated as: 
WT(i) = y*n* w(b)*k, (5) 
with y as the number of production rounds in a random pig farm in a country, per year, n as 
the number of deliveries of cross-contaminated feed batches to a random farm, per production 
stage, w(b) as the weight of a cross-contaminated feed batch and k as the number of farms with 
pigs of certain production stages in a country. The latter variable k was estimated based on the 
level of each pig farm production type in a country (e.g. percentage of single site farrow-to-
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finish farms, which have piglets, sows and fattening pigs; percentage of fattening pig farms, 
which grow only fattening pigs; etc).  
For the parametrization of this model regarding WT , we used the estimations of a previously 
developed risk model (Filippitzi et al. 2016), which concerned a country where antimicrobial 
medicated feed production represents 2% of the total feed produced per year. The results of 
this model were based on available data regarding the feed production in Belgium. This is 
also the case for the current model, which is parametrized based on: available, published (i.e. 
weight of total and medicated feed produced in Belgium, averages suggested by the BFA 
(Belgian Feed Association; e.g. BFA, 2014) and unpublished (i.e. weight of a medicated and 
non-medicated feed batch) data from the BFA; available data from two on-going research 
projects on Belgian pig farms focusing on the distribution of pig production (i.e. data on 
number of production rounds per production stage, number of pigs per production stage) and 
on the use of antimicrobial treatments of pigs via feed (i.e. frequency of feed deliveries, 
method of oral administration of antimicrobials); and expert opinion (three researchers with 
expertise in porcine health management and veterinary epidemiology and two swine 
practitioners, based in Belgium). 
Probability of residues of an antimicrobial, used for pig medicated feed production, being 
found in intestinal contents of pigs exposed to cross-contaminated feed (PT) 
With a view to estimate the probability of residues of an antimicrobial (AM) used, to be found 
in intestinal contents of pigs exposed to cross-contaminated feed (PT), the following 
mathematical expression was employed:  
PT = P * Puse, (6) 
where P is the probability of residues of an AM being found in intestinal contents of a pig 
exposed to cross-contaminated feed, while Puse is the probability of this AM being used for 
the production of pig medicated feed in a country (Table 1).  
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For this model, we estimated P by replacing in a Beta distribution (Table 1), data from Peeters 
et al. (2016) regarding the concentrations of chlortetracycline (CTC), doxycycline (DOX) and 
sulfadiazine-trimethoprim (SDZ-TRIM) found in feces, caecum and intestinal contents of 
pigs, after administration of feed containing a 3% carry-over level of these antimicrobials. In 
absence of other similar published experimental data and by considering prior research on 
bioavailability of antimicrobials in pigs (Riviere and Papich 2009), we assumed the same P 
for any other carry-over level, for the purposes of this model. This is supported by the fact 
that these AM undergo linear kinetics. 
For the calculation of Puse for the aforementioned antimicrobials, we fitted a Beta distribution 
(Table 1) based on the Belgian national data on antimicrobials premixes used for the 
production of medicated pig feed, from the 2016 Belgian Veterinary Surveillance of 
Antibacterial Consumption report (BelVet-SAC 2017). The AM premixes used for pigs 
represent the 99.3% of the total amount of AM premixes used in Belgium.  
Number of pigs, per production stage, having residues of an AM in their intestinal contents, 
as a result of exposure to cross-contaminated feed, in a country (NRes) 
The number of pigs, per production stage, with residues of an AM being found in their 
intestinal contents as a result of exposure to cross-contaminated feed, in a country (NRes(i)) can 
be estimated as follows: 
NRes(i) = N(i) * PT , (7) 
with N(i) denoting the number of pigs, per production stage i, exposed to cross-contaminated 
feed, in a country i and PT denoting the probability of residues of an antimicrobial used for 
pigs medicated feed production, being found in intestinal contents of pigs exposed to cross-
contaminated feed (Table 1). 
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This model estimated the NRes(i) of piglets, fattening pigs and sows using Belgian data, per 
antimicrobial (i.e. CTC, DOX, SDZ and TRIM). Subsequently, the uncertainty over the 
probability of a pig of a certain production stage having residues of an AM, as a result of 
exposure to cross-contaminated feed, in a country (PRes(i)) was estimated using the beta 
distribution: 
PRes(i)    ̴ RiskBeta (NRes(i)+1, S(i) - NRes(i) +1), (8) 
with S(i) denoting the pig populations per production stage i in a country (in one production 
round) (Statistics Belgium 2017).  
The proportion of pigs of a certain production stage i having residues of an AM in their 
intestinal contents, as a result of exposure to cross-contaminated feed, in a country (L(i)) was 
then estimated as: 
L(i) = PRes(i) * 100 (9) 
Model implementation 
The quantitative part of model, with PRes(i) as its final estimate, was built using @Risk® 
software (Palisade Corporation®) and was run at 10 000 iterations per simulation. Following 
a semi-quantitative approach, the model reaches a binary outcome over the potential for 
resistance selection (i.e. risk yes/negligible). According to it, there is a potential for resistance 
selection (RS1), if: 
PRes(i)  > 0 and C≥C1, (10) 
where C is the concentration of residues of an AM found in intestinal contents of pigs, as a 
result of exposure to cross-contaminated feed, C1 is the minimum known concentration of an 
AM associated with potential for resistance selection pressure, while PRes is estimated as 
shown in equation (8). We refer to a potential, as more factors seem to play a role in 
resistance development. 
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On the other hand, there is negligible potential for resistance selection (RS2), if: 
PRes(i)  > 0 and C<C1, OR PRes(i)  = 0 (11) 
Thanks to availability of experimental data (Peeters et al., 2017, 2018), doxycycline was the 
substance used as the example to discuss over the potential for resistance selection (equations 
10, 11).  
In the case of the scenarios of 1% (scenario B) and 3% (scenario C) AM carry-over levels, the 
estimation of the probabilities of a pig of a certain production stage having residues of an AM 
in its intestinal contents, as a result of exposure to cross-contaminated feed with at least 1% 
(PRes i(1)) or 3% (PRes i(3)) AM carry-over level in a country, followed the same logic as the 
estimation of PRes (Table 1). The only difference concerned the estimation of the total weights 
of cross-contaminated pig feed produced per year, with at least 1% (WT(1)) or 3% (WT(3))  AM 
carry-over level. In case of scenario B (Table 3): 
WT(1) = WI *p1 + WII *p2 + WIII *p3, (12) 
where WI, WII and WIII are the weights of cross-contaminated batches of non-antimicrobial 
medicated feed (non-AM MF) produced in a country per year at the feed-mill, the transport 
truck and the farm level, respectively, as described in Filippitzi et al. (2016); p1, p2 and p3 are 
the probabilities of a feed batch being cross-contaminated with at least 1% AM carry-over 
level at the feed mill, the transport truck and the farm level, respectively. Beta distributions 
were used to estimate p1 and p2, based on data from available literature (Putier et al. 2010; 
Stolker et al. 2012), while due to absence of data, p3 was assumed to equal p2. In the case 
where AM MF represents 2% of the total feed produced in a country, as for Belgium 
(Filippitzi et al. 2016), then equation (12) can be replaced by the formula: 
WT(1) = 0.3*WT*p1 + 0.35*WT*p2 + 0.35*WT*p3, (13) 
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where WT is the total weight of cross-contaminated pig feed produced in a country per year. 
In case of scenario C (Table 4), the total weight of cross-contaminated pig feed produced per 
year, with at least 3% AM carry-over level (WT(3)) is calculated as: 
WT(3) =  WI*p4, (14) 
with WI being the weight of cross-contaminated batches of non-AM MF produced in a 
country per year at the feed-mill level and p4 being the probability of a feed batch being cross-
contaminated at the feed mill with at least 3% AM carry-over level. For this scenario, only the 
feed-mill level is taken into consideration, as AM carry-over levels of over 3% have not been 
observed at the transport or farm levels. For the estimation of p4 a beta distribution is used, 
based on data regarding the cross-contamination of the first batches produced directly after 
batches of AM MF (Stolker et al. 2012). These so-called first flushing batches, which are 
produced to clean the production lines, can contain higher AM concentrations compared to 
the second or third. As explained for equation (12), in the case where AM MF represents 2% 
of the total feed produced in a country, then WT(3) equals: 
WT(3) = 0.3*WT*p4, (15) 
where WT is the total weight of cross-contaminated pig feed produced in a country per year. 
Moreover, in order to study the impact of the different model variables on NRes(i) (i.e. number 
of pigs, per production stage, with residues of an AM being found in their intestinal contents 
as a result of exposure to cross-contaminated feed, in a country; equation 7) sensitivity 
analyses were performed.  
Results 
Tables 5 and 6 show the number (NRes) and the proportion (%) (L(i)) of piglets, sows and 
fattening pigs in Belgium having residues of chlortetracycline (CTC), doxycycline (DOX), 
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sulfadiazine (SDZ) and trimethoprim (TRIM) in their intestinal content, as a result of 
exposure to cross-contaminated feed, estimated respectively using equations 7 and 9. This is 
estimated for the different scenarios A, B and C. Indicatively, the distributions of NRes(piglets,1) 
and L(piglets,1) with at least 1% carry-over level of DOX are shown in Figure 2. 
For each of the three scenarios, it was estimated that the majority of pigs with residues in their 
intestinal content due to cross-contaminated feed (NRes) contain residues of SDZ, followed by 
DOX. Many fewer pigs were estimated to contain residues of CTC and TRIM. For all 
scenarios and AM, the highest proportion of pigs with residues (L(i)) was estimated for sows, 
followed by piglets and fattening pigs, while in absolute values the order was reversed.   
Using equation 10 for the case of doxycycline (DOX) and given that: (a) the probability of a 
piglet, sow or fattening pig having residues of DOX, as a result of exposure to cross-
contaminated feed (PRes(i)) in Belgium has a positive value (Table 5); and that (b) the 
concentration of DOX residues found in intestinal contents of these pigs as a result of 
exposure to cross-contaminated feed (C) in case of scenario B is estimated to be higher than 
the minimum known concentration of DOX associated with potential for resistance selection 
pressure (C1 = 1 mg/L) (Peeters et al. 2017, 2018), it is concluded that there is a risk of 
potential for DOX resistance selection in Belgium (RS1: yes), considering the assumptions of 
the model.  
The results of the sensitivity analysis performed for the number of piglets with residues of 
DOX being found in their intestinal contents as a result of exposure to cross-contaminated 
feed with at least 1% carry-over level, in Belgium (NRes(piglets,1)) are shown in Figure 3. Similar 
pattern in terms of variables and ranking were also observed in the case of other production 
stages and AM.  
Discussion 
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The model estimated that mean proportions (L(i)) of 7.7% of sows, 4.2% of piglets and 2.8% 
of fattening pigs in Belgium have residues of DOX in their intestinal contents, due to 
consumption of feed cross-contaminated with at least 1% carry-over. Almost three times these 
proportion of pigs were estimated to have residues of SDZ, for the same scenario (Table 6). 
On the contrary, the estimated proportions of pigs with residues of chlortetracycline (CTC) 
and trimethoprim (TRIM) were negligible (mean values of L(i) <1) in all production stages and 
for all scenarios. In Belgium, CTC is the AM used the least as premix, while SDZ is the AM 
used the most (BelVet-SAC 2017). SDZ and TRIM, generally administrated in combination 
in a ratio TRIM:SDZ = 1:5, are both AM with high bioavailability (Nielsen et al. 1994; Baert 
et al. 2001). However, expected lower residual concentrations in intestinal content and feces 
have only been observed for TRIM (Peeters et al. 2018), as it has been shown that in the case 
of SDZ an excretion of the AM from blood back to the gut takes place (De Smet et al. 2017).  
The proportion of animals having residues of the different antimicrobials due to consumption 
of cross-contaminated feed was estimated to be higher for sows and piglets. This observation 
for sows, compared to piglets and fattening pigs, can be attributed largely to the lower 
population of sows in a production round (S(i)). To a less extent it can be attributed to the 
higher number of batches of sows in a farm (z) which are linked to different feed silos, usually 
filled at different feed deliveries (Table 1). Focusing only on carry-over at the farm level, the 
latter comment mainly concerns farms that use medicated feed in sows and not top dressing, 
which is another method often used for sow treatments. The higher proportion observed for 
piglets compared to fattening pigs can be mainly attributed to the estimation of the probability 
of the cross-contaminated feed being administered to pigs of each production stage (Pa(i)). In 
detail, the number of production rounds per year (y) and the number of farms with pigs of a 
certain production stage in Belgium (k) were higher for piglets and contributed to a higher 
estimation of Pa for this production stage (Table 2). These observations suggest that an initial 
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targeting of sows and especially piglets, in terms of prevention of AM resistance related to 
cross-contaminated feed, is required. In absolute values, the reversed order compared to 
proportions (i.e. higher number of pigs exposed to cross-contaminated feed estimated for 
fattening pigs, followed by piglets and sows) is mainly due to the differences in the size of the 
population of each production stage. The sensitivity analysis revealed that, for the same 
scenario and antimicrobial, the number of pigs in a batch, per production stage in a farm (nb) 
was the variable affecting the outcome NRes the most. Fortunately, this is a variable that was 
relatively easy to estimate and therefore with a relatively high accuracy. 
The semi-quantitative approach followed allowed us to conclude that, for the case of 
doxycycline, there is a potential for resistance selection (RS) in Belgium, since the 
concentration of DOX residues estimated to be found in pigs that have consumed cross-
contaminated feed with at least 1% carry-over level (C≥ 1	mg/L), is associated with potential 
for resistance selection pressure (Peeters et al. 2017, 2018). This is of course only one item 
playing a role in the development of resistance selection, as other factors have been suggested 
to also affect this complex and multifactorial process (e.g. the environment of the porcine 
intestinal microbiota, the dosage, frequency or route of administration, biosecurity-related 
factors) (Burow and Käsbohrer 2017). When experimental results become available which 
allow specification of P and C1, conclusions over RS could be also drawn for other commonly 
used antimicrobials (e.g. penicillins) and/or other antimicrobials, resistance to which may be 
transmitted from pigs to humans (e.g. pleuromutilins (Alban et al. 2017)).  
The quantitative part of the model is built in a way that allows its applicability to different 
countries. Therefore, in case of application, the legal framework in a country should be 
considered, given the current absence of a uniform European approach. For instance, since for 
the purposes of this paper, the model is parametrized with Belgian data, there is a possible 
overestimation of NRes for fatteners, as in Belgium, administration is forbidden to pigs > 80kg 
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of the first and second flushing batches of feed produced at the feed mill directly after 
medicated feed (BFA 2013). Additionally, the estimation of NRes for sows is possibly 
underestimated and should be interpreted as “at least”, as in most cases sows live longer than 
a year, while the value of WT used (i.e. total weight of cross-contaminated pig feed produced 
in a country) is estimated per year. Finally, to estimate WT  in another country it is 
recommended to consult the previous model (Filippitzi et al., 2016) which allows to take into 
account any differences among countries (e.g. level of medicated feed produced compared to 
total feed produced, level of import/export of total feed produced if it occurs, etc.). 
The fact that low cross-contamination levels have the potential for resistance selection to 
certain AM poses a further risk of group level resistance selection (e.g. co-selection of 
resistance genes conferring resistance to additional agents due to genetic linkages or other 
adaptations). And even though the presence of residues of other AM in intestinal contents of 
pigs is lower (e.g. TRIM) (De Smet et al. 2017), the possibility of co-resistance or cross-
resistance, mechanisms that affect different AM classes or different AM of the same class, 
cannot be excluded. Very low antibiotic levels (e.g. of tetracycline) found in animals might in 
fact also be sufficiently high to maintain multi-resistance plasmids, while they can result in 
resistance selection in combination with other compounds (i.e. other AM or metals) present in 
feed (Baker-Austin et al. 2006; Gullberg et al. 2014; Pal et al. 2015). The presence of AM 
residues in intestinal contents and feces of pigs due to consumption of cross-contaminated 
feed, adds up to the amount of AM residues present in pig manure, which may select for 
antibiotic resistance in pathogens and commensal bacteria that may enter the environment 
after fertilization. The cross-contaminated batches can reach practically any pig, even in farms 
that do not use medicated feed, causing a risk of wider concern. This means that the use of 
AM medicated feed should be avoided as much as possible, especially for preventive use. The 
use of water medication could be an alternative, as with this method, less carry-over and more 
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animals receiving a correct dose of medication are expected. In case of medicated feed 
production, good practices (e.g. regular cleaning of equipment) should be thoroughly 
followed at the feed-mill, during transport and unloading, as well as storage and distribution 
at the farm. The use of an end-of-line mixer for the production of medicated feed at the feed-
mill, a fine-dosing-truck and the use of a separate silo for medicated and non-medicated feed, 
are also ways to reduce cross-contamination at the different levels. 
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Model framework designed to estimate the number of pigs per production stage, which 
consume cross-contaminated feed and end up containing antimicrobial residues in their 
intestinal contents, in a country, and to whether there is potential for resistance selection 
Notes: 1 For piglets, sows and fattening pigs; 2 if the concentration of these residues is equal or 
higher than minimum known concentrations associated with resistance selection pressure, the 
model concludes that there is potential for resistance selection (see Table 1).  
Figure 2 
Distribution of the number (NRes(piglets)) and level (%) of piglets (L(piglets)) in Belgium  having 
residues of doxycycline (DOX) in their intestinal contents, as a result of exposure to cross-
contaminated feed with at least 1% carry-over level 
Figure 3 
Sensitivity analysis performed for the number of piglets with residues of doxycycline (DOX) 
being found in their intestinal contents as a result of exposure to cross-contaminated feed with 
at least 1% carry-over level, in Belgium (NRes(piglets,1)) 
Notes: The details of each variable are presented in Tables 1, 2 and 3. 
 
 
Table 1 
Detailed summary of distributions and formulas used to estimate the model variables, 
considering the presence of an antimicrobial in cross-contaminated batches at any possible 
concentration higher than zero (AM > 0) (scenario A) 
Notes: 1T is the total weight of feed produced or used (if feed is imported/exported) in a 
country where 2% of T is AM medicated feed and 5.5 is the mean value of this level; 2piglets, 
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sows and fattening pigs; 3assumed to equal the days of administration of a feed batch, per 
production stage; 4the discrete distribution describes wb that can take one of several explicit 
discrete values (most likely the value of 4tn); 5max values were lowered to avoid 
overestimation of nf; 6corresponds to the number of pig batches fed from the same mixing line 
and silo; 7for sows, that live over a year, this estimation is per year; 8 samples of caecum, 
intestinal content and feces; 9CTC= chlortetracycline, DOX=doxycycline, SDZ=sulfadiazine, 
TRIM=trimethoprim; 10we refer to a potential, as more factors seem to play a role in 
resistance development. 
Table 2 
Summary of the distributions and formulas used to estimate the probability of cross-
contaminated feed being administered to pigs of certain production stage (Pa(i)) 
Notes: 1This is based on the type of production in Belgian pig farms (e.g. percentage of single 
site farrow-to-finish farms, of fattening pig farms etc); 2assuming that WT is administered to 
piglets, sows and fattening pigs. The weight distributed to pigs of each production stage is 
estimated using the formula for WT(i); 3after replacing all variables in the equation, the 
specification of m is not needed. 
Table 3 
Detailed summary of distributions and formulas used to estimate the model variables in case 
of scenario B (i.e. AM carry-over level of at least 1%)  
Notes: 1 These are the weights of cross-contaminated batches of non-AM MF produced in a 
country per year (where AM MF is 2% of total feed produced) at the feed-mill level (WI), the 
transport truck level (WII) and the farm level (WIII); 2 rounded values; 3 WT is the total weight 
of cross-contaminated feed produced in a country per year. 
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Table 4 
Detailed summary of distributions and formulas used to estimate the model variables in case 
of scenario C (i.e. AM carry-over level of at least 3%)  
Notes: 1 This is the weight of cross-contaminated batches of non-MF produced in a country 
per year (where MF is 2% of total feed produced) at the feed-mill level; 2 rounded value; 3 
corresponds to first flushing batches of feed, produced directly after batches of medicated 
feed, to clean the production lines. 
Table 5 
Min, mode, mean and max values of the number of pigs per production stage having residues 
of chlortetracycline (CTC), doxycycline (DOX), sulfadiazine and trimethoprim (SDZ-TRIM) 
in their intestinal contents, as a result of exposure to cross-contaminated feed, in Belgium, for 
different scenarios (i.e. AM>0 (scenario A), at least 1% (scenario B) and 3% AM carry-over 
levels (scenario C)) 
Notes: Most values are rounded. The values for NRes(sows) are estimated per year. 
Table 6 
Min, mode, mean and max values of the level (%) of pigs per production stage having 
residues of chlortetracycline (CTC), doxycycline (DOX), sulfadiazine and trimethoprim 
(SDZ-TRIM) in their intestinal contents, as a result of exposure to cross-contaminated feed, in 
Belgium, for different scenarios (i.e. AM>0 (scenario A), at least 1% (scenario B) and 3% 
AM carry-over levels (scenario C)) 
Notes: The values of L(sows) are estimated per year. 
Table 1. 
Variable Description Distribution / Formula / 
Parameter estimate 
Reference 
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WT Total weight of cross-contaminated pig feed 
produced in a country per year 
=  5.5%*T 1
For BE: 
 ̴RiskLognorm(146586,6;86253;
RiskShift(209139)) 
Filippitzi et al., 2016 
Pa(i) Probability of the cross-contaminated feed 
WT being administered to pigs of certain 
production stage i 2 
Pa(pigl)= 0.782 (mean value) 
Pa(sow)= 0.015 (mean value) 
Pa(fatt)= 0.201(mean value) 
See table 2 
WT’(i) Total weight of cross-contaminated pig 
feed, administered per pig production stage 
i, in one production round 
= (WT* Pa(i))/ y  
y Number of production rounds per 
production stage in a random pig farm in a 
country, per year 
y(pigl) = 7.2 
y(sow) = 1 
y(fatt) = 2.5 
Unpublished data from 
Belgian project; expert 
opinion 
b (i) Intake of cross-contaminated feed per pig 
during a production stage i 
= bd*da*n = (wb*n) / nb  
bd Feed intake per pig at different production 
stages, per day 
  
da Days of administration of a cross-
contaminated feed batch3, per production 
stage 
= wb / (bd * nb)  
wb Weight of a cross-contaminated feed batch 
(tn) 
 ̴RiskDiscrete(1, 4) 4 BFA (unreferenced) 
n Number of deliveries of cross-contaminated 
feed batches to a random farm, per 
production stage 
n(pigl)  ̴RiskPert(1;1;2) 
n(sow)  ̴RiskPert(0;0;1) 
n(fatt) = 1 
Unpublished data from 
Belgian project; expert 
opinion 
nb Number of pigs in a batch, per production 
stage in a farm, in a country 
= nf / z  
nf Number of pigs per production stage in a 
farm, in a country 
nf(pigl)  ̴RiskPert(200;800;950)  
nf(sow)  ̴RiskPert(200;400;600) 
nf(fatt)  ̴RiskPert(200;750;900) 
Unpublished data from 
Belgian project 5; expert 
opinion 
z Number of batches of pigs per production 
stage in a farm, in a country6 
z(pigl)  ̴RiskPert(1;2;2) 
z(sow)=3 
z(fatt)  ̴RiskPert(1;1;2) 
Unpublished data from 
Belgian project; expert 
opinion 
N(i) Number of pigs, per production stage i, 
exposed to cross-contaminated feed7 
= WT’(i) / b(i)  
S(i) Pig populations per production stage i in a 
country (in one production round) 
S(pigl) = 1 533 564 
S(sow) = 416 877 
S(fatt) = 4 061 013 
Landbouwgegevens, 2017 
P Probability of residues of an AM being 
found in intestinal contents of a pig 
exposed to cross-contaminated feed 
  ̴RiskBeta (c+1, d-c+1) 
 
 
c Number of samples8 from pigs receiving 
cross-contaminated feed, found with 
residues of an AM 
c(CTC)= 54; c(DOX)= 54; c(SDZ)= 54; 
c(TRIM)= 2 9 
Peeters et al., 2016 
d Total number of samples8 from pigs 
receiving cross-contaminated feed, tested 
for residues of an AM 
d(CTC)= 54; d(DOX)= 54; d(SDZ)= 54; 
d(TRIM)= 54 
Peeters et al., 2016 
Puse Probability of an AM being used for the 
production of pig MF in a country 
  ̴RiskBeta(e+1, f-e+1) 
 
 
e Amount of an AM used as premix for 
medicated pig feed (kg) 
e(CTC)= 36 kg; e(DOX)= 4 975 kg;  
e(SDZ)= 14 181 kg; e(TRIM)= 2 836 
BelVet Sac data, 2017 
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kg 
f Total amount of all AM used as premixes for 
medicated pig feed (kg) 
35 698 kg 
 
BelVet Sac data, 2017 
PT  Probability of residues of an AM used for 
pig MF production, being found in intestinal 
contents of pigs exposed to cross-
contaminated feed 
= P * Puse  
NRes (i) Number of pigs per production stage i 
having residues of an AM in their intestinal 
contents, as a result of exposure to cross-
contaminated feed, in a country7 
= N(i) * PT  
PRes(i)  Probability of a pig of a certain production 
stage having residues of an AM in its 
intestinal contents, as a result of exposure 
to cross-contaminated feed, in a country  
  ̴RiskBeta (NRes(i)+1, S(i) - NRes(i) 
+1)  
 
 
L(i) Level of pigs of a certain production stage i 
having residues of an AM in their intestinal 
contents, as a result of exposure to cross-
contaminated feed, in a country 
= PRes(i) * 100  
C1 Concentration of residues of an AM is 
associated with potential for resistance 
selection pressure (minimum known 
concentration) 
e.g. for DOX, 1 mg/L  Peeters et al., 2017 
RS1 Risk of potential for resistance selection10  If PRes > 0 and C≥C1,  
where C is the concentration of 
residues of an AM found in 
intestinal contents of pigs, as a 
result of exposure to cross-
contaminated feed 
 
RS2 Negligible risk of potential for resistance 
selection10 
If PRes > 0 and C<C1, OR 
If PRes = 0 
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Table 2. 
Variable Description Distribution / Formula Reference 
WT(i) Total weight of cross-contaminated pig 
feed administered to pigs of a certain 
production stage i, per year 
WT(i) = y*n* w(b)*k  
y Number of production rounds in a random 
pig farm in a country, per year 
 
 
See Table 1 
n Number of deliveries of cross-
contaminated feed batches to a random 
farm, per production stage 
 See Table 1 
w(b) Weight of a cross-contaminated feed batch  See Table 1 
k Number of farms with pigs of certain 
production stages in a country 
k(pigl) = 70%*m 
k(sow) = 70%*m 
k(fatt) = 60%*m, 
where m is the total number of pig 
farms in the country 
Expert 
opinion1 
WT Total weight of cross-contaminated pig 
feed produced in a country per year 
WT = WT(pigl)+ WT(sow)+WT(fatt)2  
Pa(i) Probability of cross-contaminated feed 
being administered to pigs of certain 
production stage 
= WT(i) / WT 3
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Table 3. 
Variable Description  Distribution / Formula Reference  
WT(1) Total weight of cross-
contaminated pig feed 
produced per year, with at 
least 1% AM carry-over level 
=  WI *p1 +  WII *p2 +  WIII *p3 1= 
= 0.3*WT*p1 + 0.35*WT*p2 + 
0.35*WT*p3  2, 3 
Filippitzi et al., 
2016 
p1 Probability of a first flushing 
batch being cross-
contaminated at the feed mill 
level with at least 1% AM 
carry-over level 
̴beta(69+1, 140-69+1) 
 
Zuidema et al., 
2010 
Stolker et al., 
2013 
p2 Probability of a non-AM 
medicated feed batch being 
cross-contaminated at the 
transport truck level with  at 
least 1% AM carry-over level 
̴beta(1+1, 20-1+1) 
 
Putier et al., 
2010 
 
p3 Probability of a non-AM 
medicated feed batch being 
cross-contaminated at the 
farm level with  at least 1% 
AM carry-over level 
 ̴beta(1+1, 20-1+1) 
 
Assumed  
WT’(1) Total weight of the cross-
contaminated pig feed 
produced per year, with at 
least 1%  AM carry-over level, 
administered to pigs of a 
certain production stage i  
= WT(1) *  Pa(i) See table 2 
Ni(1) Number of pigs, per 
production stage, exposed to 
cross-contaminated feed with 
at least 1% AM  carry-over 
level, in a country  
= WT’(1) / b(i) See  table 1 
NRes i(1) Number of pigs per 
production stage i having 
residues of an AM in their 
intestinal contents, as a result 
of exposure to cross-
contaminated feed, with at 
least 1% AM  carry-over level, 
in a country  
= Ni(1) * PT  See  table 1 
PRes i(1) Probability of a pig of a certain 
production stage having 
residues of an AM in its 
intestinal contents, as a result 
of exposure to cross-
contaminated feed, with at 
least 1% AM  carry-over level, 
in a country   
  ̴RiskBeta(NRes i(1) +1,S(i) - NRes i(1) 
+1) 
See  table 1 
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Table 4. 
 
Variable Description Distribution / Formula Reference 
WT(3) Total weight of cross-contaminated pig 
feed produced per year, with at least 3% 
AM carry-over level 
=  WI1 *p4 = 0.3*WT*p4 2 Filippitzi et 
al., 2016 
 
p4 Probability of a feed batch3 being cross-
contaminated at the feed mill with  at 
least 3% AM carry-over level 
 ̴Riskbeta(28+1, 140-28+1) Zuidema et 
al., 2010; 
Stolker et 
al., 2013 
WT’(3) Total weight of the cross-contaminated 
pig feed produced per year, with at least 
3%  AM carry-over level, administered to 
pigs of a certain production stage i  
= WT(3) *  Pa(i) See table 2 
Ni(3) Number of pigs, per production stage, 
exposed to cross-contaminated feed 
with at least 3% AM  carry-over level, in 
a country  
= WT’(3) / b(i) See  table 1 
NRes i(3) Number of pigs per production stage i 
having residues of an AM in their  
intestinal contents, as a result of 
exposure to cross-contaminated feed, 
with at least 3% AM  carry-over level, in 
a country  
= Ni(3) * PT  See  table 1 
PRes i(3) Probability of a pig of a certain 
production stage having residues of an 
AM in its intestinal contents , as a result 
of exposure to cross-contaminated feed, 
with at least 3% AM  carry-over level, in 
a country   
  ̴RiskBeta(NRes i(3) +1,S(i) -NRes i(3) 
+1) 
See  table 1 
Ac
ce
pte
d M
an
us
cri
pt
 
 
 
Table 5.  
AM/Scenarios NRes(piglets) NRes(sows) NRes(fatteners) 
min mode mean max min mode mean max min mode mean max 
CTC 
Scenario A 461 1 786 2 341 15 820 223 624 1 182 8 930 997 2 404 4 101 21 925 
Scenario B 867 204 499 4 073 39 149 248 1 468 155 571 860 6 037 
Scenario C 31 70 144 760 15 37 72 347 50 148 249 1 861 
DOX 
Scenario A 76 346 169 007 310 674 2 013 987 35 295 91 595 157 109 736 312 116 196 320 425 536 733 2 943 168 
Scenario B 13 548 45 195 65 468 444 481 5 805 18 086 33 404 273 115 21 185 61 977 113 086 1 126 081 
Scenario C 3 892 8 804 18 897 132 342 1 767 4 372 9 552 42 915 7 052 18 509 33 176 161 028 
SDZ 
Scenario A 224 425 519 542 881 644 4 477 727 104 619 242 285 448 736 2 518 046 344 660 786 368 1 538 395 8 245 206 
Scenario B 41 322 79 556 184 343 972 388 16 407 53 199 93 272 540 265 52 316 178 628 325 431 1 764 878 
Scenario C 13 156 32 287 53 947 354 529 4 826 16 253 27 523 143 193 20 010 57 137 94 325 490 433 
TRIM 
Scenario A 235 5 849 9 564 66 119 106 1 735 4 907 38 116 738 4 222 16 820 101 521 
Scenario B 41 860 2 058 14 863 2 174 1 025 12 006 46 1 723 3 530 28 161 
Scenario C 14 250 586 5 093 6 120 298 1 912 25 561 1 043 11 793 
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Table 6.  
AM/Scenarios L(piglets) L(sows) L(fatteners) 
min mode mean max min mode mean max min mode mean max 
CTC 
Scenario A 0.03 0.07 0.15 0.82 0.05 0.19 0.29 1.56 0.02 0.06 0.1 0.55 
Scenario B <0.01 0.02 0.03 0.19 <0.01 0.03 0.06 0.32 <0.01 0.01 0.02 0.13 
Scenario C <0.01 <0.01 <0.01 0.05 <0.01 <0.01 0.02 0.12 <0.01 <0.01 <0.01 0.04 
DOX 
Scenario A 5.33 10.57 20.13 94.39 9.24 20.38 34.75 99.74 3.45 9.21 13.17 49.26 
Scenario B 1.01 2.79 4.23 18.78 1.67 4.57 7.76 36.94 0.51 1.29 2.8 14.9 
Scenario C 0.27 0.87 1.23 5.47 0.41 1.31 2.3 12.1 0.19 0.53 0.81 3.93 
SDZ 
Scenario A 15.71 28.94 46.15 99.99 28.39 54.83 64.49 99.69 8.28 17.91 35.27 99.67 
Scenario B 2.42 5.91 12.01 57.73 4.28 10.19 22.4 98.90 1.81 6.42 7.99 38.95 
Scenario C 0.74 2.76 3.52 19.64 1.28 4.22 6.55 40.17 0.37 1.09 2.32 10.74 
TRIM 
Scenario A 0.03 0.41 0.63 4.91 0.07 0.41 1.15 13.51 <0.01 0.19 0.41 6.38 
Scenario B <0.01 0.05 0.13 1.25 <0.01 0.08 0.25 2.73 <0.01 0.06 0.09 0.56 
Scenario C <0.01 0.02 0.03 0.34 <0.01 0.04 0.07 0.58 <0.01 0.01 0.02 0.21 
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Figure 1 
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